-+ 0.00%
-+ 0.00%
-+ 0.00%

Craig-Hallum Maintains Buy on Champions Oncology, Raises Price Target to $12

Benzinga·03/12/2025 14:09:49
Listen to the news
Craig-Hallum analyst Matt Hewitt maintains Champions Oncology (NASDAQ:CSBR) with a Buy and raises the price target from $8 to $12.